Compare BV & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BV | EVO |
|---|---|---|
| Founded | 1939 | 1993 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2018 | 2021 |
| Metric | BV | EVO |
|---|---|---|
| Price | $12.78 | $3.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $14.63 | $7.00 |
| AVG Volume (30 Days) | ★ 558.7K | 89.0K |
| Earning Date | 02-03-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $2,688,300,000.00 | $887,396,457.00 |
| Revenue This Year | $3.86 | N/A |
| Revenue Next Year | $2.70 | $8.52 |
| P/E Ratio | $175.77 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.06 | $2.84 |
| 52 Week High | $17.11 | $4.80 |
| Indicator | BV | EVO |
|---|---|---|
| Relative Strength Index (RSI) | 44.41 | 50.42 |
| Support Level | $12.37 | $3.38 |
| Resistance Level | $13.94 | $3.82 |
| Average True Range (ATR) | 0.36 | 0.09 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 27.48 | 38.64 |
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.